Sees FY25 free cash flow $6.5B. The company said, “The Company issued its full-year 2025 GAAP diluted EPS guidance range of $4.58 to $4.83 and its 2025 Adjusted EPS guidance range of $5.75 to $6.00. The Company also issued its full-year 2025 cash flow from operations guidance of approximately $6.5 billion. The adjustments between full-year 2025 GAAP diluted EPS and Adjusted EPS include amortization of intangible assets, acquisition-related integration costs, office real estate optimization charges and the corresponding income tax benefit or expense related to the items excluded from adjusted income attributable to CVS Health (CVS).”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVS:
- Notable companies reporting before Monday’s open
- Buy Rating for CVS Health Amid Fiscal Year 2025 Guidance and Medicare Advantage Turnaround Prospects
- CVS Health Is About to Report Q4 Earnings Tomorrow. Here’s What to Expect
- Options Volatility and Implied Earnings Moves This Week, February 10 – February 14, 2025
- CVS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Questions or Comments about the article? Write to editor@tipranks.com